Bhagiradha Chemicals & Industries reported a 11% year-over-year revenue increase to Rs. 123.80 crores in Q1 FY26. However, EBITDA declined by 25% to Rs. 9.00 crores, and PAT decreased by 30% to Rs. 4.00 crores due to pricing pressures and increased costs. The company maintains a strong export focus with 97% of revenue from international markets. A significant capacity expansion plan is underway, with Phase I expected to be operational by September 2025. The company introduced Pinoxaden, a new herbicide product, and targets 5x revenue growth over the next 6-7 years through innovation, backward integration, and capacity expansion.
12Aug 25
Bhagiradha Chemicals Reports 11.7% Revenue Growth in Q1, Converts ₹367.53 Crore Subsidiary Loan to Equity
Bhagiradha Chemicals & Industries reported a 11.7% increase in Q1 revenue to ₹123.78 crore and a 14.6% rise in net profit to ₹8.29 crore. The company converted a ₹367.53 crore loan to its subsidiary, Bheema Fine Chemicals, into equity shares. It adopted a reduced corporate tax rate of 22%, resulting in a ₹3.08 crore deferred tax liability reduction. The company raised ₹341.18 crore through preferential issue of convertible warrants, primarily for funding a new manufacturing unit and working capital requirements.
07Aug 25
Bhagiradha Chemicals Secures Exchange Approval for Promoter Group Reclassification
Bhagiradha Chemicals & Industries has received approval from BSE and NSE to reclassify three individuals from 'Promoter Group' to 'Public' category. The reclassification involves T Kalyan Chakravarthi, Potini Vijaya Lakshmi, and Ramalakshmi Tulasi Padmavathy Kolli, who collectively hold 189,740 shares (0.15% of total shareholding). The approval process, initiated on May 29, 2025, was completed on August 07, 2025, in compliance with SEBI regulations.
28May 25
Bhagiradha Chemicals Q4 Results: EBITDA and Net Profit Decline Amid Revenue Growth
Bhagiradha Chemicals' Q4 results show revenue growth of 9% to ₹1.20 billion, but profitability declined. EBITDA fell 48.6% to ₹72.00 million, with EBITDA margin contracting from 12.64% to 5.90%. Net profit decreased by 35.8% year-over-year to ₹52.00 million. The company faces challenges in maintaining profitability despite revenue growth.